市場調查報告書
商品編碼
1543622
美國脊椎外科市場評估:依產品、依手術、依適應症、依程序、依最終用戶、依地區、機會、預測,2017-2031年United States Spine Surgery Market Assessment, By Products, By Surgery, By Disease Indication, By Procedure, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
美國脊椎手術市場規模預計將從2023年的48.6億美元成長到2031年的68億美元,2024-2031年預測期間年複合成長率為 4.19%。該市場的成長得益於背部和脊椎損傷、退化性椎間盤疾病、脊椎感染和椎間盤疼痛病例數量的增加,主要市場參與者對開發新技術的投資不斷增加,以及人們對侵入性外科手術技術的日益偏好。
Christopher & Dana Reeve 基金會估計,每年報告約 18,000 例新的脊髓損傷病例。這種成長推動美國脊椎手術市場的需求,因為脊髓損傷通常需要手術去除可能壓迫脊椎的異物、骨頭碎片、椎骨骨折和椎間盤突出。
日本日益嚴重的肥胖威脅也是支持市場擴張的主要因素。美國國家糖尿病、消化和腎臟疾病研究所估計,美國近三分之一的成年人超重。這種成長推動市場需求,因為體重過重可能導致減震椎間盤擠壓和突出,需要進行外科手術。
隨著技術的進步,美國的脊椎手術預計將為醫療保健提供者提供創新的解決方案,透過提高手術精度來改善患者的治療效果並縮短康復時間,推動需求。主要市場參與者也致力於開發設備以提高患者便利性和治療慢性下背痛。2024年 4月,Medtronic Plc獲得美國食品藥物管理局(FDA)批准 Inceptiv,這是一種閉環可充電脊髓刺激器。初始脊髓刺激器透過感測生物訊號來維持根據患者需求量身定制的預定刺激。這些發展預計將支持市場擴張並提供有利的成長機會。
本報告調查了美國脊椎手術市場,並提供了市場概況,以及依產品、手術、適應症、手術、最終用戶、地區的趨勢以及進入市場的公司概況等。
United States spine surgery market is projected to witness a CAGR of 4.19% during the forecast period 2024-2031, growing from USD 4.86 billion in 2023 to USD 6.80 billion in 2031. The growth of the market is supported by the rising cases of back and spine injury, degenerative disc disease, spinal infections, and disc pain, rising investments by the key players of the market towards the development of novel technologies, and growing preference for minimally invasive surgeries.
According to the estimates of the Christopher & Dana Reeve Foundation, approximately 18,000 new cases of spinal cord injury are reported every year. This increase is propelling the United States spine surgery market demand as surgical procedures are often necessary for removing foreign objects, fragments of bones, and fractured vertebrae and herniated discs that may compress the spine as a result of spinal cord injuries.
The growing threat of obesity in the country is another major factor supporting the expansion of the market. According to the estimates of the National Institute of Diabetes and Digestive and Kidney Diseases, nearly 1 in 3 adults in the United States are overweight. This rise bolsters the market demand as excessive weight can cause the shock-absorbing discs to become pinched or herniated, resulting in the requirement for surgical procedures.
Technological Advancements Support Market Expansion
Technological advancements are propelling the demand for spine surgeries in the United States as they are expected to offer innovative solutions that allow healthcare providers to enhance patient outcomes and decrease recovery time by improving surgical precision. The key market players are also focusing on developing devices to improve patient convenience and manage chronic back pain. In April 2024, Medtronic Plc received approval from the US Food and Drug Administration (FDA) for their closed-loop and rechargeable spinal cord stimulator, Inceptiv. The inceptive spinal cord stimulators maintain the prescribed stimulation tailored to the patient's requirements by sensing biological signals. Such developments are expected to support market expansion and provide lucrative growth opportunities.
Increasing Cases of Spinal Cord Injury Bolster Market Demand
The rising cases of spinal cord injuries in the United States are expected to provide lucrative growth opportunities to the market. As per the estimates of the Christopher & Dana Reeve Foundation, approximately 302,000 individuals are living with spinal cord injury in the United States. This increase is propelling the requirement for spine surgeries in the countries as they are required to keep the bones in the proper position while they are undergoing healing. The results of spinal cord injuries often vary depending upon the location and type of the injury and can result in slowing of autonomic nerve function and loss of sensory and motor functions, among others.
Growing Preference for Minimally Invasive Procedures Boosts the Market
The growing preference for minimally invasive spine surgeries among patients can be attributed to their increasing awareness about the various advantages offered by them including less pain after the procedure due to limited tissue and muscle damage, decreased loss of blood, and reduced risk of infection. Due to the rising number of minimally invasive spine surgery procedures, the key players of the market are actively investing towards the development of devices that enhance the convenience of the surgeons and ensure the smooth completion of the surgery. In April 2023, Orthofix Medical Inc. announced the launch of two access retractor systems for minimally invasive spine procedures. The Fathom Pedicle-Based Retractor System and Lattus Lateral Access System expanded Orthofix's offerings of access solutions for addressing the various requirements associated with minimally invasive procedures. The Lattus system addresses the important areas of lateral spine surgery, including plate fixation, removal or preparation of the disc, interbody placement, and easy access to the spine.
Spinal Fusion Devices Hold Significant Share of the Market
The spinal fusion device helps heal fusions and provides additional spine stability. They also aid in correcting malalignment, enhancing spinal fusion, and improving the overall stability of the spine by restricting movement in the treated spinal segment, securing bone graft material, and serving as a medium to replace the spinal disc. Due to the rising requirement for spinal fusion devices, the key players of the market are increasingly focusing on new product launches, further aiding the growth of the segment. In November 2023, in the United States, Orthofix Medical Inc. commercially launched their WaveFormL system, which is intended for lateral lumbar interbody fusion procedures.
Future Market Scenario (2024-2031F)
As per the United States spine surgery market analysis, the market demand is expected to increase significantly in the coming years due to rising obesity in the country and increasing investments by the key market players towards the introduction of new devices and systems. Boston Scientific Corporation is conducting an interventional study for compiling the real-world outcomes of the Superion Indirect Decompression System (IDS) in routine clinical trials, when the directions of use are followed. The study is expected to conclude in June 2029. Additionally, the growing awareness about spine health and the availability of different devices for managing and treating various conditions is also expected to support the market's expansion in the United States.
Key Players Landscape and Outlook
The growth of the United States spine surgery market is supported by the increasing investments by the key players of the market towards the introduction of novel products and technologies in the country. In January 2024, Abbott Laboratories announced that their Liberta RC deep brain stimulation (DBS) system was approved by the United States Food and Drug Administration (U.S. FDA). The system features NeuroSphere Virtual Clinic, which supports the programming of the system remotely. The Liberta RC DBS system is a first-of-its-kind technology that allows patients in the United States to receive new treatment settings and communicate with their doctors remotely. The company developed the system after research showcases that Abbott DBS users in the United States travel over 150 miles, on average, to meet with a movement disorder specialist. Such introductions and approvals are expected to enhance consumer convenience and aid companies in expanding their customer base in the country.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.